JP2014520893A5 - - Google Patents

Download PDF

Info

Publication number
JP2014520893A5
JP2014520893A5 JP2014521796A JP2014521796A JP2014520893A5 JP 2014520893 A5 JP2014520893 A5 JP 2014520893A5 JP 2014521796 A JP2014521796 A JP 2014521796A JP 2014521796 A JP2014521796 A JP 2014521796A JP 2014520893 A5 JP2014520893 A5 JP 2014520893A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
mammal
administration
pain
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014521796A
Other languages
English (en)
Japanese (ja)
Other versions
JP6320917B2 (ja
JP2014520893A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/047453 external-priority patent/WO2013013076A1/en
Publication of JP2014520893A publication Critical patent/JP2014520893A/ja
Publication of JP2014520893A5 publication Critical patent/JP2014520893A5/ja
Application granted granted Critical
Publication of JP6320917B2 publication Critical patent/JP6320917B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014521796A 2011-07-20 2012-07-19 疼痛を治療する方法 Active JP6320917B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161509886P 2011-07-20 2011-07-20
US61/509,886 2011-07-20
PCT/US2012/047453 WO2013013076A1 (en) 2011-07-20 2012-07-19 Methods of treating pain

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017012343A Division JP2017110022A (ja) 2011-07-20 2017-01-26 疼痛を治療する方法

Publications (3)

Publication Number Publication Date
JP2014520893A JP2014520893A (ja) 2014-08-25
JP2014520893A5 true JP2014520893A5 (https=) 2015-09-10
JP6320917B2 JP6320917B2 (ja) 2018-05-09

Family

ID=47558482

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014521796A Active JP6320917B2 (ja) 2011-07-20 2012-07-19 疼痛を治療する方法
JP2017012343A Pending JP2017110022A (ja) 2011-07-20 2017-01-26 疼痛を治療する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017012343A Pending JP2017110022A (ja) 2011-07-20 2017-01-26 疼痛を治療する方法

Country Status (16)

Country Link
US (1) US20140221490A1 (https=)
EP (2) EP2734212B1 (https=)
JP (2) JP6320917B2 (https=)
KR (1) KR20140063583A (https=)
CN (1) CN103781484A (https=)
AU (1) AU2012283915B2 (https=)
BR (1) BR112014001335A2 (https=)
CA (1) CA2841964A1 (https=)
DK (1) DK2734212T3 (https=)
ES (1) ES2646226T3 (https=)
IL (1) IL230433A0 (https=)
IN (1) IN2014CN00315A (https=)
MX (1) MX350463B (https=)
MY (1) MY166036A (https=)
NO (1) NO2854815T3 (https=)
WO (1) WO2013013076A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580954B2 (en) * 2006-03-28 2013-11-12 Hospira, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
CA2723672C (en) 2007-05-11 2019-09-03 Adynxx, Inc. Gene expression and pain
WO2009061744A2 (en) 2007-11-06 2009-05-14 Edison Pharmaceuticals, Inc. 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
EP3511022A1 (en) 2012-05-10 2019-07-17 Adynxx, Inc. Formulations for the delivery of active ingredients
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
JP6705807B2 (ja) 2014-08-15 2020-06-03 エーダイニクス インコーポレイテッド 疼痛を治療するためのオリゴヌクレオチドデコイ
US20200017853A1 (en) * 2016-02-29 2020-01-16 Adynxx, Inc. Compositions and methods for pain amelioration via modification of gene expression
US20180025116A1 (en) * 2016-07-22 2018-01-25 Arizona Board Of Regents On Behalf Of University Of Arizona Clinical Event Management and Communication System
HRP20240485T1 (hr) 2017-08-24 2024-07-05 Novo Nordisk A/S Pripravci glp-1 i njihova upotreba
US20200027555A1 (en) * 2018-07-17 2020-01-23 Lewis Pharmaceutical Information, Inc. Patient centric drug analysis platform
PE20230819A1 (es) * 2020-02-18 2023-05-19 Novo Nordisk As Composiciones y usos de glp-1
CN111494446B (zh) * 2020-05-18 2021-08-17 深圳市宝安中医院(集团) 治疗胆绞痛的中药组合物及其应用
CA3230068A1 (en) * 2021-08-31 2023-03-09 Ethismos Research, Inc. Methods of preventing and treating pain and associated symptoms

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8506792D0 (en) 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US6407079B1 (en) 1985-07-03 2002-06-18 Janssen Pharmaceutica N.V. Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5389681A (en) 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
IL111184A (en) 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
ZA949182B (en) 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
WO2001098329A1 (en) 2000-06-22 2001-12-27 Theravance, Inc. Polyhydroxy glycopeptide derivatives
JP2005514443A (ja) 2002-01-15 2005-05-19 アルタナ ファルマ アクチエンゲゼルシャフト パントプラゾール・シクロデキストリン包接錯体
US6869939B2 (en) 2002-05-04 2005-03-22 Cydex, Inc. Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
EP1680341B1 (en) * 2003-11-04 2011-05-11 Otis Elevator Company Automatic passenger conveyor slow speed operation
DK1574221T3 (da) 2004-03-10 2007-07-16 Shimoda Biotech Pty Ltd Stabile, injicérbare diclofenacsammensætninger
US8580954B2 (en) * 2006-03-28 2013-11-12 Hospira, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
KR20090010953A (ko) * 2006-03-28 2009-01-30 자블린 파머슈티칼스 인코포레이티드 저 복용량의 비-스테로이드성 항염증성 약물 및 베타-사이클로덱스트린 제형
CN101264086A (zh) 2007-03-14 2008-09-17 南京师范大学 含有头孢克肟环糊精包合物的药物组合物及其制备方法
WO2009089269A1 (en) * 2008-01-07 2009-07-16 Javelin Pharmaceuticals, Inc. Methods of treating pain while minimizing adverse effects on platelet function
US7662858B2 (en) * 2008-05-23 2010-02-16 Aaipharma, Inc. Method of treating post-surgical acute pain

Similar Documents

Publication Publication Date Title
JP2014520893A5 (https=)
KR101900520B1 (ko) 복합 조성물
PH12012501480A1 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
WO2009129509A3 (en) Methods and compositions for treating post-operative pain comprising a local anesthetic
JP2011503162A5 (https=)
MX2014002459A (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodos de uso de los mismos.
EP2331095A4 (en) CYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF USE THEREOF
JP2018520189A5 (https=)
HK1198619A1 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
MX2015017307A (es) Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington.
AU2013308465B2 (en) Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine
PH12017502049A1 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
EA201492010A1 (ru) Применение высокой дозы лахинимода для лечения рассеянного склероза
JP2016510343A5 (https=)
RU2013127420A (ru) Способы уменьшения психогенного или компульсивного переедания
RU2012108439A (ru) Способы лечения опухолей головного мозга
ES2725151T3 (es) Un producto medicinal y tratamiento
FI3352735T3 (fi) Pitkitetysti vapauttavia olantsapiiniformulaatioita
BRPI0510895A (pt) formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t
JP2011500589A5 (https=)
Del Rosso et al. Effectiveness and safety of modified-release doxycycline capsules once daily for papulopustular rosacea monotherapy results from a large community-based trial in subgroups based on gender
JP2019535830A5 (https=)
ES2668943T3 (es) Composición farmacéutica para tratar eyaculación precoz y método de tratamiento de la eyaculación precoz
CA2469702A1 (en) Darifenacin for use in the treatment of urgency induced by overactive bladder
CA2576926A1 (en) Use of midostaurin for treating gastrointestinal stromal tumors